'Conceptual Language' Hides Health Care's Costs
A Commentary By Michael Barone
Some of the headlines in recent days are not worthy of belief. No, I'm not referring to the headlines that Barack Obama won the Nobel Peace Prize, however odd that many seem to many (including, it seems, Obama himself). I'm referring to the headlines earlier in the week to the effect that the health care bill sponsored by Senate Finance Committee Chairman Max Baucus will cut the federal deficit by $81 billion over the next 10 years.
Yes, that is what the Congressional Budget Office estimated. But, as the CBO noted, there's no actual Baucus bill, just some "conceptual language." Actual language, CBO noted, might result in "significant changes" in its estimates. No wonder Democratic congressional leaders killed requirements that the actual language be posted on the Internet for 72 hours before Congress votes.
More significant is the number most publications did not put in their headlines and lead paragraphs: CBO's estimate that the Baucus "conceptual language" would increase federal spending by $829 billion over 10 years. So how do you increase federal spending and cut the deficit at the same time?
One way is taxes. The Baucus conceptual language includes a tax on high-cost insurance plans ($210 billion), penalties for not having insurance ($27 billion) and "indirect offsets" (whatever they are -- $83 billion).
In addition, costs are fobbed off on state governments in the form of more Medicaid spending, and savings are projected from future reductions in Medicare that will surely turn out to be imaginary (Congresses of both parties have acted to prevent such reductions every year since 2003).
We know from past experience that cost estimates of all government health care programs (except the 2003 Medicare Part D prescription drug benefit, which has private market competition) tend to understate actual costs. So the Baucus bill -- er, conceptual language -- if enacted is likely to expand government spending by more than the estimated $829 billion.
And perhaps quite a bit more. The Baucus measure enables families without employer-provided insurance to obtain it at exchanges with subsidies that make it cost less than what those with employer-provided insurance pay. The latter are a majority of voters -- how long are their elected representatives going to let this disadvantage stand?
The Baucus measure subsidizes low-income families. Say you make $48,000 a year and get a $900 subsidy. As your income rises, this subsidy would be phased out, raising your effective marginal tax rate to as much as 70 percent. How long will Congress let this stand?
And perhaps even more. The Wall Street Journal's Kimberley Strassel points out that well-placed senators are getting special favors in the bill. Majority Leader Harry Reid gets the feds to pick up Nevada's extra Medicaid spending. Charles Schumer gets many high-cost insurance plans in New York exempted from tax. How long before other members seek similar breaks for their states?
The Baucus bill attempts to force more Americans to buy health insurance policies designed according to government specifications, which means they will be very expensive and consumers will be shielded from costs. But that's likely to produce an increased demand for health care procedures and bend the cost curve not downward but upward.
Market incentives like those in Part D that might shift it downward are pretty much absent from the Baucus bill. All this will still, according to CBO, leave 25 million Americans without health insurance.
CBO estimaters are constrained by budget rules from guesstimating how costs will skyrocket because of political pressures. The rest of us are not. We can regard CBO's estimate of $829 billion in additional spending not as a ceiling but as a floor.
We can reasonably conclude that the Baucus bill -- or whatever similar measure Reid and Schumer concoct -- would vastly and permanently increase public sector spending and impose a crushing burden on the private sector in a weak economy. That burden would be particularly heavy on low earners forced to buy expensive policies or else pay stiff fines, with money they would otherwise receive as wages or salaries.
There are no good public policy reasons to pass such a bill hurriedly and before it can be fully analyzed and debated. Only political reasons: line up enough Democratic members before they can process the public opinion polls that show most voters hostile to such measures and before they are faced with probable though not certain Democratic defeats in Virginia and New Jersey in November.
Too bad the Nobel committee doesn't have a vote.
Michael Barone is a senior political analyst for The Washington Examiner.
COPYRIGHT 2009 THE WASHINGTON EXAMINER
DISTRIBUTED BY CREATORS.COM
See Other Political Commentaries
See Other Commentaries by Michael Barone
Views expressed in this column are those of the author, not those of Rasmussen Reports.
Rasmussen Reports is a media company specializing in the collection, publication and distribution of public opinion information.
We conduct public opinion polls on a variety of topics to inform our audience on events in the news and other topics of interest. To ensure editorial control and independence, we pay for the polls ourselves and generate revenue through the sale of subscriptions, sponsorships, and advertising. Nightly polling on politics, business and lifestyle topics provides the content to update the Rasmussen Reports web site many times each day. If it's in the news, it's in our polls. Additionally, the data drives a daily update newsletter and various media outlets across the country.
Some information, including the Rasmussen Reports daily Presidential Tracking Poll and commentaries are available for free to the general public. Subscriptions are available for $4.95 a month or 34.95 a year that provide subscribers with exclusive access to more than 20 stories per week on upcoming elections, consumer confidence, and issues that affect us all. For those who are really into the numbers, Platinum Members can review demographic crosstabs and a full history of our data.
To learn more about our methodology, click here.